We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.59%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.43T
$21.4M 4.95%
895,424
-21,452
-2% -$533K
PEP icon
2
PepsiCo
PEP
$191B
$17.4M 4.02%
164,298
-1,737
-1% -$179K
DHI icon
3
D.R. Horton
DHI
$41B
$17.1M 3.96%
544,760
-150
-0% -$4.58K
JNJ icon
4
Johnson & Johnson
JNJ
$613B
$16.3M 3.76%
134,110
+385
+0.3% +$43.7K
IBM icon
5
IBM
IBM
$213B
$14.5M 3.36%
100,239
+165
+0.2% +$23.6K
COST icon
6
Costco
COST
$423B
$13.9M 3.22%
88,785
+175
+0.2% +$26.5K
QCOM icon
7
Qualcomm
QCOM
$159B
$13.8M 3.18%
257,070
+1,000
+0.4% +$52.7K
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.57T
$13.1M 3.04%
373,480
-180
-0% -$6.61K
GE icon
9
GE Aerospace
GE
$383B
$13M 3.02%
86,490
-2,994
-3% -$437K
ICE icon
10
Intercontinental Exchange
ICE
$85.2B
$13M 3.01%
254,750
+1,000
+0.4% +$50.5K
HXL icon
11
Hexcel
HXL
$7.73B
$12.6M 2.92%
302,925
-2,950
-1% -$129K
CELG
12
DELISTED
Celgene Corp
CELG
$12.6M 2.91%
127,458
+35,435
+39% +$3.67M
APA icon
13
APA Corp
APA
$13B
$11.8M 2.73%
211,895
-25
-0% -$1.36K
PYPL icon
14
PayPal
PYPL
$49.5B
$11.5M 2.66%
315,621
+1,475
+0.5% +$56.4K
V icon
15
Visa
V
$683B
$11M 2.54%
147,925
+1,900
+1% +$149K
GS icon
16
Goldman Sachs
GS
$303B
$10.8M 2.5%
72,900
-2,720
-4% -$424K
ROP icon
17
Roper Technologies
ROP
$38.8B
$10.6M 2.45%
62,045
+240
+0.4% +$42K
AGN
18
DELISTED
Allergan plc
AGN
$10.5M 2.42%
45,231
+44,708
+8,548% +$10.3M
DIS icon
19
Walt Disney
DIS
$170B
$9.96M 2.3%
101,854
+220
+0.2% +$22K
VTRS icon
20
Viatris
VTRS
$20.5B
$9.88M 2.28%
228,380
– –
COF icon
21
Capital One
COF
$134B
$9.56M 2.21%
150,570
+250
+0.2% +$17.4K
CERN
22
DELISTED
Cerner Corp
CERN
$9.4M 2.17%
160,391
+826
+0.5% +$46K
PXD
23
DELISTED
Pioneer Natural Resource Co.
PXD
$9.29M 2.15%
61,420
+370
+0.6% +$58.1K
MDLZ icon
24
Mondelez International
MDLZ
$78.8B
$8.61M 1.99%
189,085
-2,500
-1% -$109K
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$119B
$8.45M 1.95%
+98,185
New +$8.48M
1
2 3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.